MiR-520b inhibits endothelial activation by targeting NF-κB p65-VCAM1 axis.
Sign Up to like & getrecommendations! Published in 2021 at "Biochemical pharmacology"
DOI: 10.1016/j.bcp.2021.114540
Abstract: MiR-520b belongs to the miR-373/520 family, is expressed only in human and nonhuman primates. Previous reports indicated that the expression of miR-520b was repressed in human atherosclerotic plaque tissue compared with healthy vessels. However, the… read more here.
Keywords: mir; vcam1 axis; expression; mir 520b ... See more keywords
Abstract LB-328: Mir-520b as a novel molecular target for suppressing stemness phenotype of head-neck cancer by inhibiting CD44
Sign Up to like & getrecommendations! Published in 2017 at "Cancer Research"
DOI: 10.1158/1538-7445.am2017-lb-328
Abstract: Cancer stem cells preferentially acquire the specific characteristics of stress tolerance and high mobility, allowing them to progress to a therapy-refractive state. To identify a critical molecule to regulate cancer stemness is indispensable to erratically… read more here.
Keywords: 520b novel; molecular target; cancer; mir 520b ... See more keywords
miR-520b Promotes Breast Cancer Stemness Through Hippo/YAP Signaling Pathway
Sign Up to like & getrecommendations! Published in 2019 at "OncoTargets and therapy"
DOI: 10.2147/ott.s236607
Abstract: Introduction The breast cancer stem cells contribute to the initiation, progression, recurrence, metastasis as well as resistance of breast cancer. However, the mechanisms underlying the maintenance of breast cancer stemness have not been fully understood.… read more here.
Keywords: mir 520b; hippo yap; cancer; breast cancer ... See more keywords